Search for: "Barr Consulting And Holdings, Inc."
Results 21 - 40
of 59
Sorted by Relevance
|
Sort by Date
31 Mar 2021, 3:02 am
Ass ‘n of Political Consultants, Inc., 140 S. [read post]
20 Aug 2010, 6:27 am
Barr Laboratories, Inc. 437 F.3d 1181, 1195 (Fed. [read post]
28 Jul 2010, 5:04 pm
Barr Labs., Inc., 251 F.3d 955, 968 (Fed. [read post]
24 May 2016, 9:31 am
The firm failed to obtain a distribution list for the offering document for any offerings.Alton Securities Group Inc. [read post]
2 Jul 2022, 2:22 pm
" See Hueblein, Inc. v. [read post]
14 Jan 2022, 5:57 am
Juantorena, and Julian Cardona, Cleary Gottlieb Steen & Hamilton LLP, on Monday, January 10, 2022 Tags: Accounting, Accounting standards, China, Disclosure, ESG, Foreign issuers, Form 20-F, Holding Foreign Companies Accountable Act, International governance, SEC, Securities regulation Comment Letter on DOL ESG Proposed Rulemaking Posted by Robert H. [read post]
18 Apr 2022, 8:45 pm
Consultants, Inc., 140 S. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
26 Apr 2022, 5:21 am
Consult CMS Nursing Home Compare for the most updated information. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
13 Oct 2023, 7:20 am
American Ass'n of Political Consultants, Inc. [read post]
24 Aug 2022, 5:01 am
., Inc. v. [read post]
6 May 2022, 2:21 pm
" See Hueblein, Inc. v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert… [read post]
7 Mar 2008, 2:00 am
: (Intellectual Property Watch), (Intellectual Property Watch), Statement of the IGF Dynamic Coalition on an Internet Bill of Rights at the IGF consultations in Geneva: (IP Justice), Flash! [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
4 Oct 2019, 3:00 am
Barr Personally Asked Foreign Officials to Aid Inquiry into CIA, FBI Activities in 2016 MSN – Devlin Barrett, Shane Harris, and Matt Zapotosky (Washington Post) | Published: 9/30/2019 Attorney General William Barr held private meetings overseas with foreign intelligence officials seeking their help in a Justice Department inquiry that President Trump hopes will discredit U.S. intelligence agencies’ examination of possible connections between Russia and members… [read post]
